Ara
Toplam kayıt 3, listelenen: 1-3
Serum YKL-40 levels as a novel marker of inflammation and endothelial dysfunction in patients with pseudoexfoliation syndrome
(Nature Publishing Group, 2013)
Purpose To evaluate serum levels of YKL-40 in patients with pseudoexfoliation syndrome (PEX) in comparison with those of age-and sex-matched healthy subjects. Methods Forty patients with PEX (PEX group) and 40 age- and ...
The clinical utility of pleural YKL-40 levels in diagnosing pleural effusions
(Pioneer Bioscience Publ Co, 2013)
Background and objective: Recent evidence suggests that YKL-40 is a relatively new biomarker of inflammation and it is involved in the pathogenesis of several pulmonary diseases. Details of serum and pleural YKL-40 in ...
Elevated serum YKL-40 level predicts myocardial reperfusion and in-hospital MACE in patients with STEMI
(Springer Link, 2013)
Background: Macrophages in atherosclerotic plaques secrete YKL-40, a new biomarker of acute and chronic inflammation in patients with stable CAD. We hypothesized that YKL-40 may be a specific marker reflecting the burden ...